title: Neutrophilic panniculitis associated with myelodysplastic syndrome with abnormal nuclear forms.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Becherer
authors.forename: Nicholas
authors.initials: N
authors.lastname: Golda
authors.forename: Mary
authors.initials: M
authors.lastname: Feldman
authors.forename: Alberto
authors.initials: A
authors.lastname: Diaz-Arias
authors.forename: Charles
authors.initials: C
authors.lastname: Caldwell
mesh_terms: D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use; D053144:Cell Nucleus Shape; D015913:Chelation Therapy; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy; D009504:Neutrophils / Q000473:pathology*; D015434:Panniculitis / Q000150:complications* / Q000473:pathology*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D001374:Azacitidine